Preparing India-facing medical-device documentation, assessing a device change or reviewing whether existing evidence may support the current device? Start with a scoped evidence review and a written list of gaps and next documentation steps.
MedDev Advisory provides independent ISO 10993 evidence and documentation support. An initial non-confidential fit check is free; document review and drafting are paid work with scope, deliverables and timing agreed in writing. This does not include laboratory testing, site or licensing execution, manufacturing, clinical investigation or formal submission work, and does not imply CDSCO endorsement or approval.
Device facts, materials, processes, test reports and risk-management links exist, but they do not form one traceable India-facing rationale.
A plan or report exists, but its device scope, evidence fitness, endpoint reasoning or India-facing traceability needs an independent bounded review.
You need to assess whether EU or FDA evidence may support the current device while keeping India-specific claims, assumptions and evidence limits explicit.
You need to separate biological-evaluation work from testing, site/QMS, licensing, manufacturing, clinical, applicant and submission responsibilities.
An Indian manufacturer has reports for an earlier device version and is preparing biological-evaluation documentation for the current version.
Review question: How does the tested device compare with the current materials, manufacturing, processing and sterilisation, where applicable?
Possible output: Device-to-evidence comparison and missing-input list.
Review question: Which biological-evaluation questions do the reports address, and how do they connect to the current BEP, BER or equivalent records?
Possible output: Evidence map with gaps, assumptions and evidence limits.
Review question: What needs clarification first, and which further review, execution or documentation task needs a separate owner or scope?
Possible output: Prioritised action register and proposed next documentation scope.
This fictional example does not establish evidence applicability, device equivalence, a testing decision or CDSCO acceptance. Exact outputs depend on the agreed scope and available inputs.
These recurring gaps can make the evidence difficult to assess or leave the next owner unclear. Resolving them early creates a more traceable documentation route.
Reports may name an earlier model or omit relevant material, supplier, manufacturing, processing, sterilisation or final-configuration differences.
EU or FDA records can be useful inputs, but their applicability to the current device and defined India question needs assessment rather than automatic transfer.
Biological-evaluation review is different from laboratory work, site/QMS and licensing, manufacturing, sterilisation, clinical investigation and submission execution.
Useful evidence may exist, but unresolved questions, priorities and handoffs are not recorded well enough for the manufacturer and its external providers to act.
These resources explain the evidence and documentation questions. Reading them is separate from a device-specific review or paid engagement.
The links below record specific boundary-context checks against the CDSCO Gazette index and final G.S.R. 743(E) and 744(E). They are not presented as the universal basis for every biological-evaluation scope.
The initial fit check is free. A document review is a separate paid engagement with an agreed output, fee and timeline.
Share the device category, intended body contact, India question, document inventory and timing. Do not send confidential device files initially.
If the scope fits, agree the review question, deliverable, required inputs, fee, timing and secure-sharing arrangements before work begins.
Review the evidence map, priority gaps, assumptions and recommended next owner. Stop or re-scope when execution needs fall outside the agreement.
Further documentation work needs a separate agreed scope. Laboratory, licensing, clinical-investigation and submission-execution work stays with qualified external owners.
For the free fit check, share a non-confidential device description, intended use, contact profile, immediate India question, document inventory and deadline. Supporting files are requested later through an agreed channel.
Potentially, but reuse is device- and question-specific. The review can compare the current device with the existing evidence, identify assumptions and record what remains unsupported; it does not guarantee CDSCO acceptance.
No. MedDev Advisory is an independent consulting practice, is not affiliated with or endorsed by CDSCO, and does not perform testing, manufacturing, sterilisation, packaging, clinical investigation, applicant or submission-execution roles.
No. The initial non-confidential fit check is free and does not assess documents. Any evidence review, drafting or follow-on work is scoped, priced and agreed separately before it begins.
Send a non-confidential device brief and the question or deadline you need to address. The initial fit check is free; any evidence review or documentation work is scoped and agreed separately.